Antimicrobial Resistance in Loggerhead Sea Turtles (Caretta caretta): A Comparison between Clinical and Commensal Bacterial Isolates.
Adriana TrottaMariarosaria MarinaroAlessio SposatoMichela GalganoStefano CiccarelliSerena PaciMarialaura CorrentePublished in: Animals : an open access journal from MDPI (2021)
Gram negative organisms are frequently isolated from Caretta caretta turtles, which can act as reservoir species for resistant microorganisms in the aquatic environment. C. caretta, which have no history of treatment with antimicrobials, are useful sentinel species for resistant microbes. In this culture-based study, commensal bacteria isolated from oral and cloacal samples of 98 healthy C. caretta were compared to clinical isolates from the wounds of 102 injured animals, in order to investigate the presence of AMR bacteria in free-living loggerheads from the Adriatic Sea. A total of 410 isolates were cultured. Escherichia coli and genera such as Serratia, Moraxella, Kluyvera, Salmonella were isolated only in healthy animals, while Acinetobacter, Enterobacter, Klebsiella and Morganella were isolated only from the wounds of the injured animals. When tested for susceptibility to ampicillin, amoxicillin + clavulanic acid, ceftazidime, cefuroxime, gentamicin, doxycycline, ciprofloxacin and enrofloxacin, the clinical isolates showed highly significant differences in AMR rates vs. commensal isolates for all the drugs tested, except for doxycycline. The detection of high AMR rates in loggerheads is of clinical and microbiological significance since it impacts both the choice of a proper antibiotic therapy and the implementation of conservation programs.
Keyphrases
- gram negative
- antimicrobial resistance
- escherichia coli
- multidrug resistant
- genetic diversity
- primary care
- healthcare
- public health
- risk assessment
- endothelial cells
- stem cells
- staphylococcus aureus
- drug resistant
- quality improvement
- klebsiella pneumoniae
- quantum dots
- wound healing
- smoking cessation
- biofilm formation
- candida albicans
- replacement therapy